Product Description: Wedica is a once-weekly dipeptidyl peptidase-IV (DPP-4) inhibitor. It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones* that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels. Wedica is available in tablet form for oral administration.

Product Features:

  • Once Weekly Dose.
  • Lesser hypoglycemic events.
  • 4 and 12-fold more potent than Alogliptin and Sitagliptin.
Product Name : Wedica
Generic Name : Trelagliptin Succinate
Formulation : Tablet
Available size : 2×10 ’s  and 2×8’s
Strengths : 50mg and 100mg
Registrations : Bangladesh
Website :

Categories: Anti-Diabetic